Journal
INFLAMMATORY BOWEL DISEASES
Volume 17, Issue 9, Pages 2019-2022Publisher
OXFORD UNIV PRESS INC
DOI: 10.1002/ibd.21589
Keywords
hypoxia; IBD; HIF-1; hydroxylases
Categories
Funding
- Ghent University
Ask authors/readers for more resources
As cells critically depend on oxygen for function and survival, inadequate cellular oxygenation is a major factor in the pathogenesis of a number of life-threatening diseases. Not surprisingly, cells share adaptive mechanisms to protect them against low-oxygen conditions. The recent discovery of a new family of oxygen-dependent hydroxylases has markedly increased the understanding of these adaptive processes, which in turn has led to the identification of new therapeutic targets for the treatment of conditions associated with enhanced hypoxia, such as a number of vascular and inflammatory diseases. This mini-review focuses on inhibition of hydroxylases as a potential novel treatment option for inflammatory bowel disease. Current knowledge, as well as future directions, are summarized and discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available